Microbiota-Based Therapies and Infection Prevention

Microbiota-based therapies offer innovative approaches to maintaining health by balancing the natural communities of microorganisms in the body. These therapies focus on restoring beneficial microbes to enhance immune function and reduce the risk of infections. By supporting a healthy microbiome, they contribute to infection prevention and promote overall wellness. Advances in research are expanding applications in areas such as gastrointestinal health, skin conditions, and respiratory infections. Ongoing studies continue to explore the potential of microbiota modulation as a safe and effective complement to traditional prevention strategies, highlighting its importance in modern healthcare.

    Related Conference of Microbiota-Based Therapies and Infection Prevention

    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    December 14-15, 2026

    5th Global Summit on Pharmaceutical Research

    Paris, France
    January 26-27, 2027

    22nd Annual Meet on Pharmaceutical Sciences

    Paris, France
    February 15-16, 2027

    23rd Annual Congress on Pharmacology and Toxicology

    Paris, France
    April 08-09, 2027

    21st World Drug Delivery Summit

    Vienna, Austria
    April 27-28, 2027

    10th European Biopharma Congress

    Paris, France
    April 27-28, 2027

    19th World Drug Delivery Summit

    Paris, France

    Microbiota-Based Therapies and Infection Prevention Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in